You are here

Chimerix

Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa

Fierce Pharma

Tue, 09/27/22 - 10:27 am

Emergent BioSolutions

US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout

Fierce Pharma

Tue, 08/30/22 - 11:43 am

government contract

Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table

Endpoints

Wed, 08/10/22 - 10:44 am

SIGA technologies

To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech

MedCity News

Tue, 05/17/22 - 10:46 am

Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19

MedCity News

Sun, 05/3/20 - 08:02 pm

clinical trials

Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials

Endpoints

Thu, 05/9/19 - 10:48 am

clinical trials

Chimerix cuts workforce by 20 percent after 'unexpected' trial results

Bizjournals.com

Tue, 03/1/16 - 08:58 am

Chimerix scraps two PhIII trials as it regroups in wake of a setback

Fierce Biotech

Mon, 02/22/16 - 10:09 am

clinical trials

Chimerix shares crater after late-stage trial fails

Marketwatch

Mon, 12/28/15 - 09:52 am

clinical trials

Trial enrollment drives Durham-based Chimerix stock to all-time high

Bizjournals.com

Mon, 08/3/15 - 04:57 pm

clinical trials

Chimerix aims to greatly increase R&D this year

Bizjournals.com

Sat, 06/13/15 - 09:44 am

Durham's Chimerix hits 'major milestone' in drug trial enrollment

Bizjournals.com

Tue, 06/9/15 - 10:10 am

cytomegalovirus

Analyst: Chimerix Govt. Smallpox Pact Worth Up To $435 Million

Yahoo/Benzinga

Thu, 04/16/15 - 01:05 pm

government contracts

Biotech pros' top 8 stock picks

Fortune

Mon, 03/9/15 - 11:59 am

Puma Biotechnology

Isis Pharmaceuticals

Chimerix to stop participation in clinical studies of Ebola drug

Yahoo/Reuters

Sat, 01/31/15 - 10:05 am

Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials

Yahoo/Bloomberg

Wed, 11/19/14 - 08:31 am

clinical trials

The Rationale For Using Brincidofovir (BCV) In Ebola Patients

Forbes

Thu, 11/13/14 - 08:22 am

Ebola Drug Race Ramps Up in Earnest

WSJ

Sat, 10/18/14 - 10:43 am

Tekmira Pharmaceuticals

Mapp Biopharmaceutical

Companies That Could Develop An Enterovirus Treatment

Yahoo/Benzinga

Mon, 10/13/14 - 09:16 am

Gilead Sciences

Bristol-Myers Squibb

Sarepta Therapeutics

Ebola Drug Stocks React Wildly to Dallas Patient Death

24/7 Wall St

Wed, 10/8/14 - 02:43 pm

Sarepta Therapeutics

Pages